Pulmonary function in children with systemic lupus erythematosus. 1996

I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
Institute of Respiratory Diseases, University of Pavia, Italy.

BACKGROUND Abnormalities of pulmonary function have been found in children with systemic lupus erythematosus (SLE) even in the absence of clinical or radiographic evidence of pulmonary involvement. It is unknown whether these abnormalities represent an early sign of progressive lung disease or whether they are associated with disease activity. METHODS After a mean of 4.5 years, respiratory function (forced vital capacity (FVC) and single breath gas transfer factor (TLCO)) and disease activity were reexamined in 13 of 15 previously studied children with SLE. Disease activity was assessed by a validated index of SLE activity (SLE activity measure (SLAM)). RESULTS In spite of the high prevalence of abnormalities of respiratory function at the baseline investigation, no chest radiographic abnormalities or overt clinical signs of lung disease were found at baseline, in the interval between the two investigations, or at the re-evaluation in any patient. From baseline to the second investigation the mean value of SLAM decreased and there was a trend toward an improvement in FVC and TLCO. TLCO was more severely impaired than FVC, being found as an isolated abnormality in a high percentage of patients (45% at baseline and 35% at follow up). There was a relationship between baseline TLCO and disease activity, expressed as a SLAM score. Moreover, there was a correlation between the changes in the SLAM score from baseline to the second investigation and the corresponding changes in the TLCO value, but not with the corresponding changes in the FVC value. CONCLUSIONS In this series of patients the decrease in SLE activity from the first to the second investigation was associated with an improvement in pulmonary function. The presence of early isolated functional abnormalities was not associated with subsequent development of lung disease.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D011659 Pulmonary Gas Exchange The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER. Exchange, Pulmonary Gas,Gas Exchange, Pulmonary
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
April 1966, The American review of respiratory disease,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
January 2020, Frontiers in pediatrics,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
August 1978, Revista clinica espanola,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
August 1984, Radiology,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
June 1992, The Journal of rheumatology,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
August 1988, Chest,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
July 1988, Chest,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
October 2017, Pediatric pulmonology,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
January 1989, Pediatriia,
I Cerveri, and F Fanfulla, and A Ravelli, and M C Zoia, and B Ramenghi, and L Spagnolatti, and I Villa, and A Martini
January 1996, Internal medicine (Tokyo, Japan),
Copied contents to your clipboard!